PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Capsaicin - Osteoarthritis

PAD Profile : Capsaicin - Osteoarthritis Important

Keywords :
Capsicum, PNMP, rheumatic disease
Brand Names Include :
Zacin
Important Information :
0.025% cream (Zacin brand) is licensed for this indication. (0.075% Axsain cream is NOT licensed for osteoarthritis)

Traffic Light Status

Status 1 of 1.

Status :
Green
Formulations :
  • Cream
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
06 June 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Surrey and North West Sussex Area Prescribing Committee (APC) during the update of the persistant non-malignant pain guidelines, recommends topical capsaicin (Zacin) as an adjunct to core treatment for knee or hand osteoarthritis in line with NICE guidance CG177. 

Please note that the Axsain brand is not licensed for use in osteoarthritis.

Topical capsaicin (Zacin) will be considered GREEN on the traffic light system for this indication

Associated BNF Codes

10. Musculoskeletal and Joint Diseases
10.03.02. Rubefacients, topical NSAIDs, capsaicin and poultices
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More